|The PLAA plaa (Catalog #MBS2542029) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The PLAA Monoclonal Antibody reacts with Human, Mouse, Rat and may cross-react with other species as described in the data sheet. MyBioSource\'s PLAA can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunohistochemistry (IHC), ELISA (EIA).
IHC: 1:50-1:500. Researchers should empirically determine the suitability of the PLAA plaa for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The PLAA plaa product has the following accession number(s) (GI #72534670) (NCBI Accession #NP_001026859.1) (Uniprot Accession #Q9Y263). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the PLAA Monoclonal Antibody with the following immunoassay(s):
Western Blot (WB) (Western Blot analysis of ROS1728 cells using PLAA Monoclonal Antibody at dilution of 1:1000)
Phospholipase A-2-activating protein (PLAA), also named PLAP, can interact with ubiquitin and is involved in the maintenance of ubiquitin levels. PLAA contains multiple consensus domains including WD repeats, PFU domain and PUL domain. Although the function of PLAA remains unclear, ubiquitin binding of PLAA might be the central role that connects ubiquitination and degradation in ERAD. Recent finding revealed that PLAA served as a novel nociveptive mediator after incision, and its expression level is regulated by miR-203.
Immunogen: Fusion protein of PLAA. Buffer: PBS with 0.02% sodium azide, 50% glycerol, PH7.3
Conjugation: Unconjugated. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing PLAA are readily searchable from our website. Different antibodies against the same target such as PLAA may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Disease Models, Animal, Drug-Induced Liver Injury, Inflammation, Kidney Diseases, Liver Diseases, Lung Diseases, Necrosis, Nervous System Diseases, Neurotoxicity Syndromes, Poisoning are some of the diseases may be linked to PLAA Monoclonal Antibody. The following patways have been known to be associated with this gene. PLAA also interacts with the following gene(s): CAV1, PDIA3, VCP. Adipose Tissue, Blood, Bone, Brain, Connective Tissue, Kidney, Liver, Lung, Muscle, Vascular tissues are correlated with this protein.